Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01964924
Title Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field